Exodus Point Capital Management, LP Sio Gene Therapies Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.29 - $2.36 $27,615 - $50,520	-21,407 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.81 - $2.7 $31,856 - $47,520	-17,600 Reduced 45.12%	21,407 $46,000
Q2 2021 Aug 16, 2021	BUY	$2.07 - $2.89 $54,049 - $75,460	26,111 Added 202.47%	39,007 $106,000
Q1 2021 May 17, 2021	SELL	$2.34 - $3.44 $44,181 - $64,950	-18,881 Reduced 59.42%	12,896 $34,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $60,694 - $178,904	31,777 New	31,777 $88,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.